Skip to content

Clinical trials

Chronic Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Disease Clear all

776 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20024
20038
200413
20059
200613
200711
200814
200917
201018
201124
201215
201327
201433
201540
201636
201742
201856
201947
202044
202155
202241
202352
202451
202550
202643

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed467
Unknown status106
Recruiting87
Not yet recruiting33
Terminated31
Active, not recruiting30
Enrolling by invitation10
Withdrawn9
Suspended2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VA Office of Research and Development17
McMaster University12
University of California, San Francisco12
University of Washington10
Stanford University9
US Department of Veterans Affairs9
University of Michigan9
Assistance Publique - Hôpitaux de Paris7
University of Alabama at Birmingham7
Central Hospital, Nancy, France6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Disease776
Diabetes Mellitus98
Hypertension72
Obesity57
Cardiovascular Diseases52
Pulmonary Disease, Chronic Obstructive37
Diabetes Mellitus, Type 232
Neoplasms29
Anxiety Disorders27
Heart Failure27

Trials

Showing 51 to 75 of 776. Each trial links to its page on Pharma Observatory.

676 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.